These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 28760504

  • 1. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
    Son M, Oh S, Park H, Ahn H, Choi J, Kim H, Lee HS, Lee S, Park HJ, Kim SU, Lee B, Byun K.
    Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis.
    Park MJ, Lee SH, Moon SJ, Lee JA, Lee EJ, Kim EK, Park JS, Lee J, Min JK, Kim SJ, Park SH, Cho ML.
    Sci Rep; 2016 Nov 02; 6():35933. PubMed ID: 27804999
    [Abstract] [Full Text] [Related]

  • 4. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
    Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Yan S, Schmidt AM, Chen JX, Yan SS.
    FASEB J; 2010 Apr 02; 24(4):1043-55. PubMed ID: 19906677
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
    Cho HJ, Son SM, Jin SM, Hong HS, Shin DH, Kim SJ, Huh K, Mook-Jung I.
    FASEB J; 2009 Aug 02; 23(8):2639-49. PubMed ID: 19332646
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.
    Kim DH, Lim H, Lee D, Choi SJ, Oh W, Yang YS, Oh JS, Hwang HH, Jeon HB.
    Sci Rep; 2018 Jan 10; 8(1):354. PubMed ID: 29321508
    [Abstract] [Full Text] [Related]

  • 10. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population.
    Ataç ZS, Alaylıoğlu M, Dursun E, Gezen-Ak D, Yılmazer S, Gürvit H.
    J Clin Neurosci; 2019 Jan 10; 59():197-201. PubMed ID: 30389362
    [Abstract] [Full Text] [Related]

  • 11. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS, Learman CR, Ahn KC, Baker GB, Kippe J, Field EM, Dunbar GL.
    Neuroscience; 2015 Oct 29; 307():37-50. PubMed ID: 26297896
    [Abstract] [Full Text] [Related]

  • 12. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease.
    Webster SJ, Mruthinti S, Hill WD, Buccafusco JJ, Terry AV.
    Neuromolecular Med; 2012 Jun 29; 14(2):119-30. PubMed ID: 22415896
    [Abstract] [Full Text] [Related]

  • 13. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice.
    Wang H, Chen F, Du YF, Long Y, Reed MN, Hu M, Suppiramaniam V, Hong H, Tang SS.
    Neuropharmacology; 2018 Mar 15; 131():143-153. PubMed ID: 29248482
    [Abstract] [Full Text] [Related]

  • 14. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease.
    Hu Q, Yu B, Chen Q, Wang Y, Ling Y, Sun S, Shi Y, Zhou C.
    Mol Med Rep; 2018 Jan 15; 17(1):827-834. PubMed ID: 29115637
    [Abstract] [Full Text] [Related]

  • 15. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling.
    Park R, Kook SY, Park JC, Mook-Jung I.
    Cell Death Dis; 2014 Jun 26; 5(6):e1299. PubMed ID: 24967961
    [Abstract] [Full Text] [Related]

  • 16. Aβ1-42 oligomer induces alteration of tight junction scaffold proteins via RAGE-mediated autophagy in bEnd.3 cells.
    Chan Y, Chen W, Wan W, Chen Y, Li Y, Zhang C.
    Exp Cell Res; 2018 Aug 15; 369(2):266-274. PubMed ID: 29856989
    [Abstract] [Full Text] [Related]

  • 17. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
    Zhou R, Chen LL, Yang H, Li L, Liu J, Chen L, Hong WJ, Wang CG, Ma JJ, Huang J, Zhou XF, Liu D, Zhou HD.
    Curr Alzheimer Res; 2021 Aug 15; 18(5):428-442. PubMed ID: 34488598
    [Abstract] [Full Text] [Related]

  • 18. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
    Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ, Thiyagarajan M, Zarcone T, Fritz G, Friedman AE, Miller BL, Zlokovic BV.
    J Clin Invest; 2012 Apr 15; 122(4):1377-92. PubMed ID: 22406537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
    Bae JS, Jin HK, Lee JK, Richardson JC, Carter JE.
    Curr Alzheimer Res; 2013 Jun 15; 10(5):524-31. PubMed ID: 23036020
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.